Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,800
Sort by:
Hematologic Malignancies Treatment Market - 2026-2033
US$ 3,400.00
Hematologic Malignancies Treatment Marketis is growing with a CAGR of 7.80% during the forecast period 2026-2035. The Hematologic Malignancies Treatment Market emerges as a key focus in DataM Intellig...
May 2026
60 pages
Non-invasive Cancer Diagnostics Market Size, Share & Trends Analysis Report By Product (Pathology-based Instruments, Imaging Instruments), By Technology (Imaging, Liquid Biopsy, Immunoassay), By Indication, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
Non-invasive Cancer Diagnostics Market The global non-invasive cancer diagnostics market size was estimated at USD 80.87 billion in 2025 and is projected to reach USD 139.09 billion by 2033, growing a...
May 2026
125 pages
Glioblastoma Treatment Market - 2026-2033
US$ 3,400.00
Glioblastoma Treatment Marketis is growing with a CAGR of 8.70% during the forecast period 2026-2035. The Glioblastoma Treatment Market emerges as a key focus in DataM Intelligence latest in-depth ana...
May 2026
48 pages
U.S. Non-Invasive Cancer Diagnostics Market Size, Share, & Trends Analysis Report By Product (Pathology-based Instruments, Imaging Instruments), By Technology, By Indication, By End User, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
U.S. Non-Invasive Cancer Diagnostics Market The U.S. non-invasive cancer diagnostics market size was estimated at USD 27.08 billion in 2025 and is projected to reach USD 47.52 billion in 2033, growing...
May 2026
100 pages
Pheochromocytoma Market - 2026-2033
US$ 3,400.00
Pheochromocytoma Market reached USD 2.16 billion in 2025 and is expected to reach USD 3.86 billion by 2033, growing with a CAGR of 8.50% during the forecast period 2026-2033. The Pheochromocytoma Mark...
May 2026
42 pages
Molecular Oncology Diagnostics Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Product Type (Instruments, Kits and Assays, Software), By Technology (Fluorescence In-Situ Hybridization (FISH), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Flow Cytometry, and Other Technologies), By Application (Research, Clinical), By Cancer Type ({Solid Tumor (Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, and Other Solid Tumors), Blood Cancers (Lymphoma, Leukemia, Multiple Myeloma, and other Hematological Malignancies)}, By End User (Hospitals and Diagnostic Centers, Reference Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Molecular Oncology Diagnostics Market is anticipated to expand from USD 3.76 billion in 2025 to USD 8.39 billion by 2031, reflecting a compound annual growth rate of 14.31%. This field invo...
May 2026
182 pages
Pancreatic Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type {Diagnostic Imaging Tests (CT scan, MRI, Ultrasound, Others), Biopsy, Blood Tests, Liver Function Tests, Others}, By Cancer Type (Exocrine, Adenocarcinoma, Squamous Cell Carcinoma, Colloid Carcinoma, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pancreatic Cancer Diagnostics Market is anticipated to expand from USD 3.01 Billion in 2025 to USD 4.59 Billion by 2031, reflecting a 7.29% CAGR, and encompasses a variety of medical tests...
May 2026
185 pages
Bile Duct Cancer Market - 2026-2033
US$ 3,400.00
Bile Duct Cancer Marketis is growing with a CAGR of 8.20% during the forecast period 2026-2035. The Bile Duct Cancer Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...
April 2026
42 pages
Breast Cancer Diagnostics Market Forecasts to 2034 – Global Analysis By Product (Instrument-based Products and Platform-based Products), Type (Biopsy, Imaging, Blood Tests, Genomic Tests, Nuclear Medicine Diagnostics, Histopathology and Other Types), Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Breast Cancer Diagnostics Market is accounted for $6.22 billion in 2026 and is expected to reach $12.77 billion by 2034 growing at a CAGR of 9.4% during the fo...
April 2026
200 pages
Prostate Cancer Diagnostics Market Forecasts to 2034 – Global Analysis By Test Type (Preliminary Tests, Confirmatory Tests, Immunohistochemistry and Other Test Types), Cancer Type (Benign Prostatic Hyperplasia, Prostatic Adenocarcinoma, Small Cell Carcinoma and Other Cancer Types), End User (Hospitals, Outpatient Facilities, Diagnostic Laboratories, Cancer Research Institutes, Home Care, Research & Manufacturing and Other End Users) and by Geography
US$ 4,150.00
According to Stratistics MRC, the Global Prostate Cancer Diagnostics Market is accounted for $11.1 billion in 2026 and is expected to reach $20.9 billion by 2034 growing at a CAGR of 8.23% during the...
April 2026
200 pages
Gall Bladder Cancer Treatment Market - 2026-2033
US$ 3,400.00
Gall Bladder Cancer Treatment Market reached USD 93.2 million in 2025 and is expected to reach USD 142.4 million by 2033, growing with a CAGR of 5.50% during the forecast period 2026-2033. The Gall Bl...
April 2026
55 pages
Glioblastoma Multiforme Market - 2026-2033
US$ 3,400.00
Glioblastoma Multiforme Marketis is growing with a CAGR of 9.60% during the forecast period 2026-2035. The Glioblastoma Multiforme Market emerges as a key focus in DataM Intelligence latest in-depth a...
April 2026
49 pages
Pancreatic Cancer Diagnostic Market Size, Share & Trends Analysis Report By Product, Test Type (Imaging Test, Biopsy, Blood Test), By Cancer Type (Exocrine, Endocrine), By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global pancreatic cancer diagnostic market size was estimated at USD 2.80 billion in 2025 and is projected to reach USD 5.15 billion by 2033, growing at a CAGR of 6.83% from 2026 to 2033. The incr...
April 2026
150 pages
Ovarian Cancer Market - 2026-2033
US$ 3,400.00
Ovarian Cancer Marketis is growing with a CAGR of 23.70% during the forecast period 2026-2035. The Ovarian Cancer Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where se...
April 2026
40 pages
Anal Cancer Market - 2026-2033
US$ 3,400.00
Anal Cancer Marketis is growing with a CAGR of 6.60% during the forecast period 2026-2035. The Anal Cancer Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned...
April 2026
37 pages
Malignant Mesothelioma Therapeutics Market - 2026-2033
US$ 3,400.00
Malignant Mesothelioma Therapeutics Market reached USD 0.8 billion in 2025 and is expected to reach USD 1.2 billion by 2033, growing with a CAGR of 8.50% during the forecast period 2026-2033. The Mali...
April 2026
61 pages
